HK1200359A1 - Antibody recognizing arbitrarily designed epitope of three or more amino acid residues in a peptide and method of generating thereof - Google Patents
Antibody recognizing arbitrarily designed epitope of three or more amino acid residues in a peptide and method of generating thereofInfo
- Publication number
- HK1200359A1 HK1200359A1 HK15101049.2A HK15101049A HK1200359A1 HK 1200359 A1 HK1200359 A1 HK 1200359A1 HK 15101049 A HK15101049 A HK 15101049A HK 1200359 A1 HK1200359 A1 HK 1200359A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- peptide
- generating
- amino acid
- acid residues
- antibody recognizing
- Prior art date
Links
- 125000000539 amino acid group Chemical group 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1036—Retroviridae, e.g. leukemia viruses
- C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
- C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Oncology (AREA)
- AIDS & HIV (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161535988P | 2011-09-17 | 2011-09-17 | |
PCT/US2012/055771 WO2013040564A2 (en) | 2011-09-17 | 2012-09-17 | Antibody recognizing arbitrarily designed epitope of three or more amino acid residues in a peptide and method of generating thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1200359A1 true HK1200359A1 (en) | 2015-08-07 |
Family
ID=47884023
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK15101049.2A HK1200359A1 (en) | 2011-09-17 | 2015-01-30 | Antibody recognizing arbitrarily designed epitope of three or more amino acid residues in a peptide and method of generating thereof |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP2755687A4 (xx) |
JP (2) | JP2014527085A (xx) |
CN (1) | CN104039350B (xx) |
AU (2) | AU2012308212A1 (xx) |
CA (1) | CA2855781A1 (xx) |
HK (1) | HK1200359A1 (xx) |
WO (1) | WO2013040564A2 (xx) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10245313B2 (en) | 2014-10-24 | 2019-04-02 | Versitech Limited | DNA motif compounds and methods for inducing specific antibodies and cellular immunity |
CN111153996B (zh) * | 2020-01-10 | 2021-12-14 | 苏州睿瀛生物技术有限公司 | G蛋白偶联受体的抗体及其制备方法和g蛋白偶联受体试剂盒 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU8091694A (en) * | 1993-10-26 | 1995-05-22 | United Biomedical Inc. | Structured synthetic antigen libraries as diagnostics, vaccines and therapeutics |
AU8087994A (en) * | 1993-10-26 | 1995-05-22 | Syntello Inc. | Inhibition of hiv mucosal infection |
US6441140B1 (en) * | 1998-09-04 | 2002-08-27 | Cell Signaling Technology, Inc. | Production of motif-specific and context-independent antibodies using peptide libraries as antigens |
US9289487B2 (en) * | 1999-09-14 | 2016-03-22 | Antigen Express, Inc. | II-key/antigenic epitope hybrid peptide vaccines |
FR2809402A1 (fr) * | 2000-05-26 | 2001-11-30 | Dev Des Antigenes Combinatoire | Bibliotheques peptidiques combinatoires convergentes et leur application a la vaccination contre le virus de l'hepatite c |
EP1725099A4 (en) * | 2004-02-02 | 2009-08-19 | Mixture Sciences Inc | MIXTURES OF PEPTIDES WITH IMMUNOMODULATORY ACTIVITY |
CA2701948A1 (en) * | 2007-10-09 | 2009-04-16 | Technologie Integrale Ltd. | Hiv preventive vaccine based on hiv specific antibodies |
-
2012
- 2012-09-17 EP EP12832007.4A patent/EP2755687A4/en not_active Withdrawn
- 2012-09-17 WO PCT/US2012/055771 patent/WO2013040564A2/en active Application Filing
- 2012-09-17 CA CA2855781A patent/CA2855781A1/en not_active Abandoned
- 2012-09-17 AU AU2012308212A patent/AU2012308212A1/en not_active Abandoned
- 2012-09-17 JP JP2014530928A patent/JP2014527085A/ja active Pending
- 2012-09-17 CN CN201280045106.2A patent/CN104039350B/zh not_active Expired - Fee Related
-
2015
- 2015-01-30 HK HK15101049.2A patent/HK1200359A1/xx unknown
-
2017
- 2017-04-18 JP JP2017082368A patent/JP2017141291A/ja active Pending
- 2017-10-24 AU AU2017251715A patent/AU2017251715A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2013040564A2 (en) | 2013-03-21 |
JP2017141291A (ja) | 2017-08-17 |
JP2014527085A (ja) | 2014-10-09 |
WO2013040564A3 (en) | 2013-06-27 |
AU2017251715A1 (en) | 2017-11-09 |
CN104039350A (zh) | 2014-09-10 |
CA2855781A1 (en) | 2013-03-21 |
CN104039350B (zh) | 2019-07-05 |
AU2012308212A1 (en) | 2014-03-27 |
EP2755687A2 (en) | 2014-07-23 |
EP2755687A4 (en) | 2015-04-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1249406A1 (zh) | 芳族陽離子肽和使用它們的方法 | |
HK1247628A1 (zh) | 多特異性fab融合蛋白及其使用方法 | |
ZA201308251B (en) | Amino acid sequence presenting fusion polypeptide and its use | |
HK1223550A1 (zh) | 芳香族陽離子肽及其用途 | |
HK1199892A1 (en) | Modified mini-hepcidin peptides and methods of using thereof | |
IL230918A0 (en) | Modified proteins and peptides | |
HK1244540A1 (zh) | 芳香族陽離子肽及其用途 | |
HK1197028A1 (en) | Aromatic-cationic peptides and uses of same | |
GB2501332B (en) | Photo-dissociation of proteins and peptides in a mass spectrometer | |
IL229353B (en) | Dolestatin derivatives related to unnatural amino acids and medicinal preparations that include them | |
HK1201443A1 (en) | Aromatic-cationic peptides and uses of same | |
EP3210997C0 (en) | MEANS AND METHOD FOR EXPRESSING AND SECRETING PEPTIDES AND PROTEINS | |
EP2797629A4 (en) | AGLYCOSYLATED HUMAN ANTIBODY AND FUSION PROTEIN AND USES THEREOF | |
EP2747773A4 (en) | METHODS AND COMPOSITIONS COMPRISING A PEPTIDE DERIVED FROM THE B-TERMINAL END OF BAX | |
SI2839003T1 (sl) | Zmanjšanje tvorbe amidiranih aminokislin v celičnih linijah za izražanje proteinov | |
HK1200359A1 (en) | Antibody recognizing arbitrarily designed epitope of three or more amino acid residues in a peptide and method of generating thereof | |
EP2695892A4 (en) | PEPTIDE THAT CAN INDUCE ANTIBODY ABLE TO RECOGNIZE HIV STEREOSTRUCTURE | |
IL234753B (en) | A method for preparing a recombinant peptide and the prepared peptide | |
EP2680879A4 (en) | PEPTID LINKERS FOR POLYPEPTIDE COMPOSITIONS AND APPLICATION METHOD THEREFOR | |
EP2771689A4 (en) | PEPTIDES USP2A AND ANTIBODIES | |
EP2577537A4 (en) | PROCESS FOR PREPARING PEPTIDES OF A LIPID-ACTIVATED ENZYME AND PEPTIDES MADE THEREOF | |
GB201121233D0 (en) | Modified proteins and peptides | |
GB201121226D0 (en) | Modified proteins and peptides | |
GB201121236D0 (en) | Proteins and peptides |